In infants and toddlers who had a stroke before birth or as a newborn (28 days or younger), a treatment that combined ...
Kandu Health today announced positive results from the first randomized controlled trial of its brain-computer interface (BCI ...
News Medical on MSN
High-dose motor therapy improves outcomes after perinatal stroke
In infants and toddlers who had a stroke before birth or as a newborn (28 days or younger), a treatment that combined ...
An at-home brain-computer interface improves upper limb motor function in patients with chronic stroke, suggesting a new avenue for long-term neurorehabilitation.
When patients have serious medical conditions such as a stroke, they need intensive rehabilitation after being released from ...
MedPage Today on MSN
Stroke Trial Tips Scale Further to Favor Intra-Arterial Lytic After EVT
CHOICE-2 supports intra-arterial alteplase after successful reperfusion ...
An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...
News-Medical.Net on MSN
Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...
Therapy dogs eased the loneliness and isolation of patients in a hospital for psychiatric care, helping their treatment, ...
Harford County woman Sarah Bochenick's stroke recovery story highlights how quick medical response can save lives and prevent ...
7d
Bayer Aktiengesellschaft Spotlights OCEANIC-STROKE Data: Asundexian Cuts Recurrent Stroke Risk 26%
Bayer Aktiengesellschaft (ETR:BAYN) highlighted results from its OCEANIC-STROKE phase III trial during an investor webinar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results